Articolul precedent |
Articolul urmator |
343 2 |
Ultima descărcare din IBN: 2022-09-09 20:58 |
SM ISO690:2012 URSU, Alexandr, ROJNOVEANU, Gheorghe. The impact of the COVID-19 on colorectal cancer screening. In: Cercetarea în biomedicină și sănătate: calitate, excelență și performanță, Ed. 1, 20-22 octombrie 2021, Chişinău. Chișinău, Republica Moldova: 2021, p. 248. ISBN 978-9975-82-223-7 (PDF).. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Cercetarea în biomedicină și sănătate: calitate, excelență și performanță 2021 | ||||||
Conferința "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță" 1, Chişinău, Moldova, 20-22 octombrie 2021 | ||||||
|
||||||
Pag. 248-248 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. Colorectal cancer (CRC) is the third type of cancer globally diagnosed. Detecting of the early stages would reduce mortality. Since the onset of COVID-19, medical resources have been redirected, resulting in a sharp decline in CRC screening. Objective of the study. Presentation of recent information on the impact of COVID-19 in the early detection of CRC. Material and Methods. Bibliographic sources from the Medline, PubMed, Google Academic databases for the years 2019 – 2021 were used to study the effects of the COVID-19 on the early detection of CRC. The search was perfomed by the following keywords: colorectal cancer, COVID-19, screening. Results. The processing of articles from online databases, in accordance with the search criteria, highlighted 63 works: 18 – dedicated to barriers in detecting of CRC, 11 – on the adaptation of screening methods, 14 – on open access colonoscopy, 12 – related to medical factors and 8 – to factors related to patients who blocked CRC screening. Thus, the negative effect of Covid-19 was determined by reducing the early diagnosis rate of CRC by 85%. The causes being: redistribution of medical and financial resources, limitation of endoscopic investigations, stopping of examinations and scheduled interventions. Conclusion. The COVID-19 has severaly disrupted CRC screening, and its adaptation requires the implementation of individualized screening strategies, more accessible and convenient options for patient compliance. |
||||||
Cuvinte-cheie colorectal cancer, COVID-19, diagnosis of CRC, colonoscopy, screening, cancer colorectal, COVID-19, diagnostic a CCR, colonoscopie, screening |
||||||
|